Phase I, Dose Escalation Study of Decitabine

NCT02264873 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Lymphoblastic, Acute
Leukemia, Myeloid Acute
Hematopoetic Myelodysplasia

Interventions

DRUG: Decitabine

Sponsor

University of Florida

Collaborators

[object Object]